| Followers | 40 |
| Posts | 5751 |
| Boards Moderated | 0 |
| Alias Born | 04/12/2021 |
Saturday, July 03, 2021 9:33:29 AM
Long time until actual revenue for this company apparently, till then gap games,
Pump by Bezos with some Amazon dollars, fill the gap slowly, repeat, till 2022 imo
Pump by Bezos with some Amazon dollars, fill the gap slowly, repeat, till 2022 imo
my posts are always theory and not financial advice
Recent NAUT News
- Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 • GlobeNewswire Inc. • 04/09/2026 12:00:00 PM
- Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference • GlobeNewswire Inc. • 03/24/2026 12:00:00 PM
- Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform • GlobeNewswire Inc. • 03/18/2026 12:00:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/05/2026 12:33:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:31:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:31:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:31:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:31:07 PM
- Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026 • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference • GlobeNewswire Inc. • 02/19/2026 09:05:00 PM
- Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 • GlobeNewswire Inc. • 02/05/2026 01:00:00 PM
- Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease • GlobeNewswire Inc. • 01/28/2026 01:00:00 PM
- Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay • GlobeNewswire Inc. • 01/08/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/11/2025 02:29:14 AM
- Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging • GlobeNewswire Inc. • 11/03/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/28/2025 08:11:59 PM
- Nautilus Biotechnology Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 10/28/2025 12:00:00 PM
- Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025 • GlobeNewswire Inc. • 10/07/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2025 10:34:20 PM
- Nautilus Biotechnology to Participate in Upcoming September Investor Conferences • GlobeNewswire Inc. • 08/27/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2025 08:35:28 PM
- Nautilus Biotechnology Reports Second Quarter 2025 Financial Results • GlobeNewswire Inc. • 07/31/2025 12:00:00 PM
- Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics • GlobeNewswire Inc. • 07/30/2025 12:00:00 PM
